At a glance
ClinicalIndex Comparison RecordN/ACompleted· 119 enrolled
Drug / intervention
Active Comparator: Approved Uncoated PleurX Indwelling Pleural Catheter +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pivotal Multi Center, Randomized, Controlled, Single-Blinded Study Comparing the Silver Nitrate Coated Indwelling Pleural Catheter to the Uncoated PleurX Catheter for the Management of Symptomatic, Recurrent, Malignant Pleural Effusions
In Brief
A clinical study evaluating Active Comparator: Approved Uncoated PleurX Indwelling Pleural Catheter and Experimental: Silver Nitrate Coated Indwelling Pleural Catheter (SNCIPC) for Malignant Pleural Effusion. Completed, enrolled 119 participants across 19 sites in 2 countries.
Detailed Summary
The purpose of this study is to determine whether a new catheter is safe and effective in treating malignant pleural effusions compared to approve catheter.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalignant Pleural Effusion
CountriesUnited Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 2016
Enrollment StartMay 2016
Primary CompletionApr 2018
TodayJul 2026
First PostedJan 8, 2016
Enrollment StartMay 1, 2016
Primary CompletionApr 18, 2018
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 10.5 years ago
Interventions
Active Comparator: Approved Uncoated PleurX Indwelling Pleural Catheterdevice
Experimental: Silver Nitrate Coated Indwelling Pleural Catheter (SNCIPC)device